Skip to main content
  • 3468 Accesses

Abstract

Cocaine produces an array of neuropsychiatric states, and the violently agitated patient is perhaps the most dramatic ED presentation caused by this drug. This person typically arrives with a multitude of personnel who are attempting physical control. There is an appearance of incredible strength, but this may reflect an indifference to pain; the risk of physical harm to both caregivers and the patient is significant. The patient is delusional, paranoid, and often overtly psychotic. This state does not clearly relate to cocaine dosage, blood level [21], route of administration, or frequency of use. It does not seem to be precipitated by adulterants or concomitant use of other drugs, with the possible exception of alcohol; the role of cocaethylene.

While there is an increasing rate of use among young adults in all western countries over the past years (Fig. 42), more often, the combination of cocaine with alcohol is being advertised as this allegedly results in a prolongation of effects. Some 99% of contemporary Western users mix cocaine and ethyl alcohol. Cocaine and alcohol combine to be metabolized to another hugely reinforcing compound, cocaethylene. Coca-use only really took off in the West when it was blended with an alcoholic beverage. However, such combination is substantially more toxic than either substance on their own. For instance, about twelve million Americans combine ethanol with cocaine to produce a pronounced and prolonged euphoria. However it is known that the combination of these two drugs is substantially toxic. This may be a result of cocaethylene, detected in the serum of emergency patients. Cocaethylene is a cocaine metabolite, formed in the liver only in the presence of ethanol [9]. Being pharmacologically active it depresses the myocardium causing cardiotoxicity [22].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Harris DS, Everhart ET, Mendelson J, Jones RT. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug Alcohol Depend. 2003;72:169–82.

    Article  PubMed  CAS  Google Scholar 

  2. Wetli CV, Fishbain DA. Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci. 1985;30:873–80.

    PubMed  CAS  Google Scholar 

  3. Henning RJ, Wilson LD. Cocaethylene is as cardiotoxic as cocaine but is less toxic than cocaine plus ethanol. Life Sci. 1996;59:615–27.

    Article  PubMed  CAS  Google Scholar 

  4. Fowler JS, Volkow ND, Logan J, McGregor RR, Wang GF, Wolf AP. [11C]cocaine phrmaciokinertics in human brain and heart. Synapse. 1992;12:228–35.

    Article  PubMed  CAS  Google Scholar 

  5. Cami J, Farré M, González ML, Segura J, de la Torre R. Cocaine metabolism in humans after use of alcohol. Clinical and research implications. Recent Dev Alcohol. 1998;14:437–55.

    Article  PubMed  CAS  Google Scholar 

  6. Landry MJ. An overview of cocethylene, an alcohol-derived psychoactive, cocaine metabolite. J Psychoactive Drugs. 1992;24:273–6.

    Article  PubMed  CAS  Google Scholar 

  7. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88:325–31.

    Article  PubMed  CAS  Google Scholar 

  8. Om A. Cardiovascular complications of cocaine. Am J Med Sci. 1992;303:333–9.

    Article  PubMed  CAS  Google Scholar 

  9. Levis JT, Garmel GM. Cocaine-associated chest pain. Emerg Med Clin North Am. 2005;23:1083–103.

    Article  PubMed  Google Scholar 

  10. Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006;24:103–14.

    Article  PubMed  Google Scholar 

  11. Eichhorn EJ, Peacock E, Grayburn PA, et al Chronic cocaine abuse is associated with accelerated atherosclerosis in human coronary arteries. J Am Coll Cardiol. 1992;19:105A.

    Article  Google Scholar 

  12. Mouhaffel AH, Madu EC, Satmary WA, Fraker TD. Cardiovascular complications of cocaine. Chest. 1995;107:1426–34.

    Article  PubMed  CAS  Google Scholar 

  13. Levis JT, Garmel GM. Cocaine-associated chest pain. Emerg Med Clin North Am. 2005;23:1083–103.

    Article  PubMed  Google Scholar 

  14. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med. 1994;1:330–9.

    Article  PubMed  CAS  Google Scholar 

  15. Anderson JL, Adams CD, Antman EM, et al ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol. 2007;50:e1–e157.

    Article  PubMed  Google Scholar 

  16. Brogan WC, Lange RA, Kim AS, et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18:581–6.

    Article  PubMed  Google Scholar 

  17. Hollander JE, Hoffman RS, Gennis P, et al Nitroglycerin in the treatment of cocaine associated chest pain–clinical safety and efficacy. J Toxicol Clin Toxicol. 1994;32:243–56.

    Article  PubMed  CAS  Google Scholar 

  18. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267–72.

    Article  PubMed  CAS  Google Scholar 

  19. Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med. 2003;21:39–42.

    Article  PubMed  Google Scholar 

  20. Baumann BM, Perrone J, Hornig SE, et al. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med. 2000;7:878–85.

    Article  PubMed  CAS  Google Scholar 

  21. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Arch Intern Med. 1990;112:897–903.

    CAS  Google Scholar 

  22. Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006;24:103–14.

    Article  PubMed  Google Scholar 

  23. Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med. 1992;327:361.

    PubMed  CAS  Google Scholar 

  24. Hollander JE, Hoffman RS, Gennis P, Fairweather P, Feldman JA, Fish SS, et al. Cocaine-associated chest pain: one year follow-up. Acad Emerg Med. 1995;2:179–84.

    Article  PubMed  CAS  Google Scholar 

  25. Hollander JE, Thode HC, Hoffman RS. Chest discomfort, cocaine and tobacco. Acad Emerg Med. 1995;2:238.

    Article  PubMed  CAS  Google Scholar 

  26. Welch RD, Todd K, Krause GS. Incidence of cocaineassociated rhabdomyolysis. Ann Emerg Med. 1991;20:154–7.

    Article  PubMed  CAS  Google Scholar 

  27. Green R, Kelly KM, Gabrielson T, Levine SR, Vanderzant C. Multiple intracerebral hemorrhages after smoking “crack” cocaine. Stroke. 1990;21:957–62.

    Article  PubMed  CAS  Google Scholar 

  28. Levine SR, Brust JCM, Futrell N, Ho KL, Blake D, Millikan CH, et al Cerebrovascular complications of the use of the “crack” form of alkaloidal cocaine. N Engl J Med. 1990;323:699–704.

    Article  PubMed  CAS  Google Scholar 

  29. Westover AN, McBride S, Haley R. Stroke in young adults who abuse amphetamines or cocaine. A population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64:495–592.

    Article  PubMed  Google Scholar 

  30. Schindler CW. Cocaine and cardiovascular toxicity. Addict Biol. 1996;1:31–47.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Enno Freye MD, PhD .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V.

About this chapter

Cite this chapter

Freye, E. (2009). Special Pathologies in Chronic Cocaine Use. In: Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2448-0_11

Download citation

Publish with us

Policies and ethics